Prescription drug · ANDA
Oxazepam NDC 52817-290
Oxazepam 10 mg/1 · Capsule · Oral · TruPharma, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 52817-290-10 | 52817029010 | 100 CAPSULE in 1 BOTTLE (52817-290-10)Marketed from Jun 1, 2021 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Oxazepam
- Generic name (nonproprietary)
- oxazepam
- Active ingredients
- Oxazepam — 10 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- TruPharma, LLC
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 071026
- Marketing start
- Listing expires
- DEA schedule
- CIV
- Other FDA classes
- Benzodiazepines (Chemical structure)
- Identifiers
- Product ID 52817-290_2a9ebd02-ff4a-2aa2-e063-6394a90a6fdeSPL ID 2a9ebd02-ff4a-2aa2-e063-6394a90a6fdeSPL set ID bda8bc70-3328-46f2-89d5-7ef7a061b418RxCUI 198057, 198059, 312134UNII 6GOW6DWN2AUPC 0352817292100, 0352817290106
- Pharmacologic class
- Benzodiazepine
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N452817029010followed by a unit qualifier and the quantityPackage 52817-0290-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Other NDCs under ANDA 071026
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.